uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Veeva Systems, Inc. Files Suit To Fight Unfair Business Practices That Limit Employee Rights July 17, 2017 Ethicon Release: Company Announces Acquisition Of MEGADYNE January 19, 2017 Biocept Announces Private Placement Of $2.2 Million Of Common Stock With August 9, 2017
Veeva Systems, Inc. Files Suit To Fight Unfair Business Practices That Limit Employee Rights July 17, 2017
